99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer

Cancer Recurrence, Clinical Trials, High Risk Prostate Cancer, Intermediate Risk Prostate Cancer

— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives

NCT Number: NCT04857502
Phase: Early Phase 1
Trial Summary: This exploratory study conducted under the RDRC program studies the biodistribution of 99mTc-PSMA-I&S in patients with prostate cancer who undergo pelvic lymph node dissection. Pr – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Jonsson Comprehensive Cancer Center
Acronym:

Pin It on Pinterest